<DOC>
	<DOCNO>NCT01292577</DOCNO>
	<brief_summary>This study integrate adapt cognitive remediation ( Cognitive Enhancement Therapy [ CET ] ) affect regulation ( Personal Therapy [ PT ] ) intervention 50 individual schizophrenia misuse cannabis . Participants randomize CET/PT plus treatment usual ( TAU ) TAU alone treat 18 month .</brief_summary>
	<brief_title>Adapted Cognitive/Affective Remediation Cannabis Misuse Schizophrenia</brief_title>
	<detailed_description>Schizophrenia severe chronic mental illness place significant burden individual suffer , family , society . One vex problem treatment schizophrenia high rate substance use comorbidity . The majority schizophrenia patient experience substantial cognitive affective impairment . Consistent deficit observe broad domain neurocognition ( e.g. , attention , memory , problem-solving ) , social cognition ( e.g. , perspective-taking , foresight , social cue recognition ) , affect regulation , major contributor functional impairment disorder . These cognitive affective deficit may exacerbate among schizophrenia patient misuse substance deficit untreated current pharmacotherapeutic strategy many turn cannabis drug cope . Cognitive Enhancement Therapy ( CET ) treatment prove effective improve cognition individual schizophrenia . Personal Therapy ( PT ) treatment design help individual affective deficit may lead substance misuse individual schizophrenia . This study adapt integrate CET PT test whether intervention well effective treat substance misuse schizophrenia patient usual treatment receive ( Treatment Usual TAU ) . Participation study last 18 month . Eligible participant randomly assign receive either CET/PT TAU . Participants receive CET/PT condition must able attend weekly treatment session Pittsburgh , PA. All participant complete cognitive , functional , affective outcome measure begin study , 6-months , 12-months , 18-months regardless treatment assignment . Results outcome measure use estimate effectiveness CET/PT individual schizophrenia misuse substance .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder confirm Structured Clinical Interview DSMIV Disorders ( SCID ) . Cannabis severity score moderate high Addiction Severity Index ( ASI ) . present significant cognitive disability base Cognitive Style Social Cognition Eligibility Interview Intelligence quotient ( IQ ) great 80 Ability read speak fluent English Ability attend weekly treatment session Pittsburgh , PA. Organic Brain Syndrome English Language sixth grade level Persistent suicidal homicidal behavior comorbid medical disorder produce cognitive impairment receipt substance abuse pharmacotherapies ( e.g. , naltrexone )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Cannabis</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Substance Misuse</keyword>
	<keyword>Cognition</keyword>
	<keyword>Psychosocial Treatment</keyword>
	<keyword>Cognitive Enhancement Therapy</keyword>
	<keyword>Personal Therapy</keyword>
	<keyword>Treatment Usual</keyword>
</DOC>